- Home
- GSL vs FNA Comparison
GSL vs FNA Comparison
Compare GSL & FNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSL
- FNA
- Stock Information
- Founded
- GSL 2007
- FNA 2010
- Country
- GSL Greece
- FNA United States
- Employees
- GSL N/A
- FNA N/A
- Industry
- GSL Marine Transportation
- FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GSL Consumer Discretionary
- FNA Health Care
- Exchange
- GSL Nasdaq
- FNA Nasdaq
- Market Cap
- GSL 877.6M
- FNA 852.1M
- IPO Year
- GSL 2006
- FNA 2021
- Fundamental
- Price
- GSL $22.84
- FNA $10.44
- Analyst Decision
- GSL Strong Buy
- FNA Strong Buy
- Analyst Count
- GSL 1
- FNA 5
- Target Price
- GSL $29.00
- FNA $15.60
- AVG Volume (30 Days)
- GSL 398.4K
- FNA 884.7K
- Earning Date
- GSL 11-11-2024
- FNA 11-12-2024
- Dividend Yield
- GSL 6.91%
- FNA N/A
- EPS Growth
- GSL 7.30
- FNA N/A
- EPS
- GSL 8.96
- FNA N/A
- Revenue
- GSL $701,476,000.00
- FNA $244,995,000.00
- Revenue This Year
- GSL $7.05
- FNA $17.47
- Revenue Next Year
- GSL N/A
- FNA $16.35
- P/E Ratio
- GSL $2.60
- FNA N/A
- Revenue Growth
- GSL 8.60
- FNA 18.16
- 52 Week Low
- GSL $17.69
- FNA $4.65
- 52 Week High
- GSL $30.32
- FNA $14.79
- Technical
- Relative Strength Index (RSI)
- GSL 36.58
- FNA 76.88
- Support Level
- GSL $23.40
- FNA $5.07
- Resistance Level
- GSL $24.10
- FNA $10.57
- Average True Range (ATR)
- GSL 0.70
- FNA 0.74
- MACD
- GSL -0.07
- FNA 0.37
- Stochastic Oscillator
- GSL 4.85
- FNA 94.23
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.
About FNA Paragon 28 Inc.
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.